Advancing Flow Chemistry in API Manufacturing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Advancing Flow Chemistry in API Manufacturing
Continuous flow chemistry offers potential for greater control, improved safety and environmental profiles, and efficient chemical transformations.


Pharmaceutical Technology
Volume 37, Issue 4, pp. 78-82

References

1. P. Van Arnum, Pharm. Technol. (36), 7, 50 (2012).

2. J. Hamby, “API Synthesis, Formulation Development, and Manufacturing” supplement to Pharm. Technol. 34, s18–19 (2010).

3. N. Korman et al., “API Synthesis, Formulation Development, and Manufacturing” supplement to Pharm. Technol. 34 , s32–s36 (2010).

4. P. Van Arnum, Pharm. Technol. 35 (8), 52–56 (2011).

5. S.A. May et al., Org. Process Res. Dev. 16 (5), 982-1002 (2012).

6. M.D. Johnson et al., Org. Process Res. Dev. 16 (5), 1017-1038 (2012).

7. S.Y. Wong et al., Org. Process Res. Dev. , online, DOI: 10.1021/op400011s, Mar.17, 2013.

8. T. Noel et al., Agnew. Chem. Int. Ed. online, DOI: 10.1002/anie.201101480, 17 May 2011.

9. S.R. Ritter, Chem. & Eng. News 89 (23), 39 (2011).

10. C. Crosjean et al., Org. Process Res. Dev. 16 (5), 781-787 (2012).

11. T. Tsubugo, Y. Yamashita, and S. Kobayashi et al., Chem. Eur. J. 18 (43), 13624-13628 (2012).

12. T. N. Glasnov, J. Flow Chem. 3 (4), 135-141 (2012).

13. A. Nagaki et al., Chem. Eur. J. 18 (38), 11871-11875 (2012).

14. K. Terao et al., J. Flow Chem. 2 (3), 73-76 (2012).

15.M. Rueping, T. Bootwicha, and E. Sugiono, Beilstein J. Org. Chem. 8, 300-307 (2012).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
29%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here